RU2016121583ARU2016121583ARU2016121583ARU2016121583ARU 2016121583 ARU2016121583 ARU 2016121583ARU 2016121583 ARU2016121583 ARU 2016121583ARU 2016121583 ARU2016121583 ARU 2016121583ARU 2016121583 ARU2016121583 ARU 2016121583A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members
(AREA)
Claims (1)
Применение 3,5-диамино-1,2,4-тиадиазола в качестве гиполипидемического средства для снижения атерогенной дислипопротеинемии.The use of 3,5-diamino-1,2,4-thiadiazole as a lipid-lowering agent to reduce atherogenic dyslipoproteinemia.